NEFL and Huntington disease: The concentration of neurofilament light chain (NfL), measured in CSF and blood, represents axonal damage and is a prognostic biomarker of neurodegeneration.38–40 Its relationship with 1H-MRS metabolites, particularly tNAA, MI and tCre, has not previously been examined in Huntington’s disease to our knowledge.